Previous 10 | Next 10 |
Phytolon and Ginkgo Bioworks Successfully Achieve First Milestone to Produce Vibrant Natural Food Colors via Two Producing Strains PR Newswire This first milestone has made the full color palette of the yellow-to-purple spectrum accessible for Phytolon's food colors and h...
2024-01-26 12:01:25 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare stocks trudged through what was a terrible 2023 for the sector. While the S&P 500 rose by 24% during 2023, the healthcare sector managed paltry returns of 0.3%. Y...
2024-01-26 10:04:59 ET Summary Ginkgo Bioworks focuses on its Foundry and Code Base assets to offer R&D services and drive down costs for clients. The company secures a significant deal with Pfizer in the drug discovery category, demonstrating the scalability of its sales team...
2024-01-25 11:55:00 ET There never seems to be a bad time for Cathie Wood to reshape her portfolios. The founder, CEO, and main stock-picker for the Ark Invest family of exchange-traded funds has been busy adding to some of her positions this week. She has also been pruning some of her hold...
2024-01-18 21:08:20 ET Summary ARK Invest's 13F portfolio value increased by 29% this quarter, reaching approximately $16.89 billion. The top three holdings in the portfolio are Coinbase Global, UiPath, and Tesla. ARK Invest made new stakes in ProShares Bitcoin Strategy ETF an...
2024-01-16 01:55:31 ET More on Ginkgo Bioworks and Illumina Ginkgo Bioworks: Strategic Shifts Amidst Financial Uncertainty Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Ginkgo Bioworks stock slides despite reaffirming top-line guidance...
Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world PR Newswire The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric's global network BOSTON and ...
2024-01-10 08:02:20 ET Ginkgo Bioworks ( NYSE: DNA ) shares rose over 1% premarket on Wednesday after the company reaffirmed its revenue guidance for 2023 based on preliminary estimates. The company continues to expect revenue of $250M– $260M for the year, which i...
Ginkgo Bioworks Provides Business Updates at J.P. Morgan Healthcare Conference PR Newswire Expects to meet 2023 new program and revenue guidance ranges Ended the year with nearly $950 million in cash and cash equivalents, a strong balance sheet providing multi-year...
2024-01-09 07:57:00 ET Sometimes, the quest for growth leads investors to strange places. For instance, Ginkgo Bioworks (NYSE: DNA) and Shiba Inu (CRYPTO: SHIB) are both investments that people look to for exposure to big upside. But the similarities end there, and it's ...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Holdings Inc. Class A Company Name:
DNA Stock Symbol:
NYSE Market:
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals PR Newswire Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution BASEL, Switzerland ...